{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:34:44Z","timestamp":1793133284602,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015217","name":"Veloxis Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015217","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ajt.2026.07.035","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T15:16:23Z","timestamp":1786202183000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A comparative study of once-daily vs twice-daily tacrolimus in deceased donor kidney transplant recipients: a national cohort analysis"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1919-1970","authenticated-orcid":false,"given":"Gaurav","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1961-7233","authenticated-orcid":false,"given":"Ahmet B.","family":"Gungor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4895-9849","authenticated-orcid":false,"given":"Maryam E.","family":"Neyestanak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0102-273X","authenticated-orcid":false,"given":"Muzammeel D.","family":"Hada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2386-5103","authenticated-orcid":false,"given":"Muhammad","family":"Azhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0796-0157","authenticated-orcid":false,"given":"Venkatesh K.","family":"Ariyamuthu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3216-133X","authenticated-orcid":false,"given":"Abd A.","family":"Qannus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1229-2265","authenticated-orcid":false,"given":"Vikas","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2378-9302","authenticated-orcid":false,"given":"Bekir","family":"Tanriover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ajt.2026.07.035_bib1","article-title":"Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients","author":"Webster","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"25","key":"10.1016\/j.ajt.2026.07.035_bib2","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ajt.2026.07.035_bib3","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.2215\/CJN.13171215","article-title":"Acute rejection rates and graft outcomes according to induction regimen among recipients of kidneys from deceased donors treated with tacrolimus and mycophenolate","volume":"11","author":"Tanriover","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.ajt.2026.07.035_bib4","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2215\/CJN.08710814","article-title":"Induction therapies in live donor kidney transplantation on tacrolimus and mycophenolate with or without steroid maintenance","volume":"10","author":"Tanriover","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.ajt.2026.07.035_bib5","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1111\/j.1600-6143.2010.03256.x","article-title":"Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study","volume":"10","author":"Kramer","year":"2010","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.ajt.2026.07.035_bib6","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1111\/ajt.12955","article-title":"Novel once-daily extended-release tacrolimus (LCPT) versus twice-daily tacrolimus in de novo kidney transplants: one-year results of Phase III, double-blind, randomized trial","volume":"14","author":"Budde","year":"2014","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.ajt.2026.07.035_bib7","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/ajt.13935","article-title":"A steady-state head-to-head pharmacokinetic comparison of all FK-506 (tacrolimus) formulations (ASTCOFF): an open-label, prospective, randomized, two-arm, three-period crossover study","volume":"17","author":"Tremblay","year":"2017","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2026.07.035_bib8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/j.ajkd.2017.07.018","article-title":"Results of ASERTAA, a randomized prospective crossover pharmacogenetic study of immediate-release versus extended-release tacrolimus in African American kidney transplant recipients","volume":"71","author":"Trofe-Clark","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.ajt.2026.07.035_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/cpt.113","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP3A5 Genotype and tacrolimus dosing","volume":"98","author":"Birdwell","year":"2015","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.ajt.2026.07.035_bib10","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1111\/ajt.13803","article-title":"High intrapatient variability of tacrolimus concentrations predicts accelerated progression of chronic histologic lesions in renal recipients","volume":"16","author":"Vanhove","year":"2016","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.ajt.2026.07.035_bib11","doi-asserted-by":"crossref","first-page":"254","DOI":"10.5500\/wjt.v13.i5.254","article-title":"Impact of tacrolimus intra-patient variability in adverse outcomes after organ transplantation","volume":"13","author":"Morais","year":"2023","journal-title":"World J Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2026.07.035_bib12","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1038\/s41598-021-84868-5","article-title":"Association between medication adherence and intrapatient variability in tacrolimus concentration among stable kidney transplant recipients","volume":"11","author":"Ko","year":"2021","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.ajt.2026.07.035_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14036","article-title":"Impact of once-daily ER-Tac on trough concentration variability in a stable AYA renal transplant recipient cohort","volume":"25","author":"Chandran","year":"2021","journal-title":"Pediatr Transplant"},{"issue":"8","key":"10.1016\/j.ajt.2026.07.035_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13311","article-title":"Bioavailability and costs of once-daily and twice-daily tacrolimus formulations in de novo kidney transplantation","volume":"32","author":"Glander","year":"2018","journal-title":"Clin Transplant"},{"issue":"7","key":"10.1016\/j.ajt.2026.07.035_bib15","first-page":"948","article-title":"Cost-effectiveness of once-daily vs twice-daily tacrolimus among Hispanic and Black kidney transplant recipients","volume":"27","author":"Hurwitz","year":"2021","journal-title":"J Manag Care Spec Pharm"},{"issue":"9","key":"10.1016\/j.ajt.2026.07.035_bib16","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/ctr.12581","article-title":"Switching study of kidney transplant patients with tremor to LCP-TacrO (STRATO): an open-label, multicenter, prospective phase 3b study","volume":"29","author":"Langone","year":"2015","journal-title":"Clin Transplant."},{"issue":"10","key":"10.1016\/j.ajt.2026.07.035_bib17","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.ajt.2024.04.006","article-title":"Incomplete reporting of clinically significant acute rejection episodes in the national kidney transplant registry","volume":"24","author":"Yu","year":"2024","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2026.07.035_bib18","first-page":"1","article-title":"Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury","volume":"2","author":"John","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.ajt.2026.07.035_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2024.11571","article-title":"Impact of switching from immediate- or prolonged-release to once-daily extended-release tacrolimus (LCPT) on tremor in stable kidney transplant recipients: the observational ELIT study","volume":"37","author":"Giral","year":"2024","journal-title":"Transpl Int."},{"issue":"2","key":"10.1016\/j.ajt.2026.07.035_bib20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0b013e3182725532","article-title":"Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring","volume":"95","author":"Kuypers","year":"2013","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.ajt.2026.07.035_bib21","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/ajt.12035","article-title":"Conversion from twice-daily tacrolimus to once-daily extended release tacrolimus (LCPT): the phase III randomized MELT trial","volume":"13","author":"Bunnapradist","year":"2013","journal-title":"Am J Transplant"},{"issue":"24","key":"10.1016\/j.ajt.2026.07.035_bib22","doi-asserted-by":"crossref","first-page":"7802","DOI":"10.3390\/jcm13247802","volume":"13","author":"Torres","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajt.2026.07.035_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fneph.2025.1666191","article-title":"Tacrolimus intrapatient variability and rejection are associated with inferior allograft outcomes after kidney transplantation","volume":"5","author":"Javed","year":"2025","journal-title":"Front Nephrol"},{"issue":"2","key":"10.1016\/j.ajt.2026.07.035_bib24","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.transproceed.2016.02.002","article-title":"Meltdose tacrolimus pharmacokinetics","volume":"48","author":"Baraldo","year":"2016","journal-title":"Transplant Proc"},{"issue":"6","key":"10.1016\/j.ajt.2026.07.035_bib25","first-page":"721","article-title":"Optimization of initial tacrolimus dose using pharmacogenetic testing","volume":"87","author":"Thervet","year":"2010","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.ajt.2026.07.035_bib26","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1097\/00007890-200212150-00002","article-title":"Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement","volume":"74","author":"Macphee","year":"2002","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.ajt.2026.07.035_bib27","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1007\/s11095-009-9867-5","article-title":"MDR1 haplotypes conferring an increased expression of intestinal CYP3A4 rather than MDR1 in female living-donor liver transplant patients","volume":"26","author":"Hosohata","year":"2009","journal-title":"Pharm Res"},{"issue":"4","key":"10.1016\/j.ajt.2026.07.035_bib28","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/cpt.690","article-title":"Worldwide distribution of cytochrome p450 alleles: a meta-analysis of population-scale sequencing projects","volume":"102","author":"Zhou","year":"2017","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.ajt.2026.07.035_bib29","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41397-019-0144-7","article-title":"CYP3A5 gene polymorphisms and their impact on dosage and trough concentration of tacrolimus among kidney transplant patients: a systematic review and meta-analysis","volume":"20","author":"Khan","year":"2020","journal-title":"Pharmacogenomics J"},{"issue":"5","key":"10.1016\/j.ajt.2026.07.035_bib30","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/tri.12770","article-title":"LCPT once-daily extended-release tacrolimus tablets versus twice-daily capsules: a pooled analysis of two phase 3 trials in important de novo and stable kidney transplant recipient subgroups","volume":"29","author":"Bunnapradist","year":"2016","journal-title":"Transpl Int"},{"issue":"4","key":"10.1016\/j.ajt.2026.07.035_bib31","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1053\/j.ajkd.2019.02.019","article-title":"Association of kidney transplant center volume with 3-year clinical outcomes","volume":"74","author":"Sonnenberg","year":"2019","journal-title":"Am J Kidney Dis."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613526027000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613526027000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:24:56Z","timestamp":1793132696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613526027000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":31,"alternative-id":["S1600613526027000"],"URL":"https:\/\/doi.org\/10.1016\/j.ajt.2026.07.035","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparative study of once-daily vs twice-daily tacrolimus in deceased donor kidney transplant recipients: a national cohort analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2026.07.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society of Transplantation & American Society of Transplant Surgeons.","name":"copyright","label":"Copyright"}]}}